An international clinical trial has found that a new drug for Huntington’s disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating...
Travelers to many parts of the world are at risk for contracting malaria, According to the Centers for Disease Control and Prevention (CDC), approximately 1,700 cases occur each year among international...
The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously...
The U.S. Food and Drug Administration Friday granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse...
Prescribing prolonged courses of antibiotics for patients experiencing symptoms attributed to Lyme disease can lead to harmful health outcomes, says a new position paper by Canada’s infectious disease...
The United States faces a converging public health crisis as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin...
A new strategy to combat antibiotic resistance has emerged from a study led by researchers at Baylor College of Medicine. Published in the journal Molecular Cell, the report reveals for the first time...
CDC is issuing new guidance to clinicians for the treatment of severe malaria cases in the United States (U.S.). This change in treatment protocol is necessary because the only FDA-approved intravenous...
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting...
Chili’s and Maggiano’s parent company Brinker International has updated its animal welfare standards to include a commitment to working toward elimination of the use of medically important antibiotics...
This website uses cookies to provide you with the best browsing experience.
Find out more or adjust your settings.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
